125 related articles for article (PubMed ID: 7295221)
1. A comparison of the physicochemical properties of carcinoembryonic antigen in extracts of tumour tissue, ascitic and cyst fluid from ovarian cancer.
Hill R; Daunter B; Magon H; Khoo SK; Mackay EV
Aust J Exp Biol Med Sci; 1981 Aug; 59(4):469-76. PubMed ID: 7295221
[TBL] [Abstract][Full Text] [Related]
2. Nature of carcinoembryonic antigen purified from malignant ascitic fluid of serous cystadenocarcinoma of the ovary.
Hill R; Daunter B; Khoo SK; Mackay EV
Mol Immunol; 1981 Jul; 18(7):647-53. PubMed ID: 7300840
[No Abstract] [Full Text] [Related]
3. Characterization of the carcinoembryonic antigen activity associated with cyst fluids of mucinous ovarian cystadenocarcinoma.
Yamashita K; Aitio ML; Dawson JR
Cancer Res; 1979 May; 39(5):1760-5. PubMed ID: 85489
[TBL] [Abstract][Full Text] [Related]
4. Carcinoembryonic antigen in ovarian cancer: correlation of concentrations in tumour tissue, cyst fluid, ascitic fluid and peripheral blood.
Khoo SK; Hill R; Daunter B; Mackay EV
Aust N Z J Obstet Gynaecol; 1982 May; 22(2):65-70. PubMed ID: 6958253
[No Abstract] [Full Text] [Related]
5. A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms.
van Nagell JR; Pletsch QA; Goldenberg DM
Cancer Res; 1975 Jun; 35(6):1433-7. PubMed ID: 805659
[TBL] [Abstract][Full Text] [Related]
6. Evidence for common and distinct determinants of colon carcinoembryonic antigen, colon carcinoma antigen-III, and molecules with carcinoembryonic antigen activity isolated from breast and ovarian cancer.
Chism SE; Warner NL; Wells JV; Crewther P; Hunt S; Marchalonis JJ; Fudenberg HH
Cancer Res; 1977 Sep; 37(9):3100-8. PubMed ID: 69490
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and immunohistochemical studies on carcinoembryonic antigen of ovarian mucinous and serous tumors.
Tohya T; Iwamasa T; Maeyama M
Gynecol Oncol; 1986 Mar; 23(3):291-303. PubMed ID: 3514390
[TBL] [Abstract][Full Text] [Related]
8. CA 125 and carcinoembryonic antigen levels in cyst fluid, ascites and serum of patients with ovarian neoplasms.
Harłozińska A; Bar JK; Gawlikowski W; Richter R; Cisło M
Ann Chir Gynaecol; 1991; 80(4):368-75. PubMed ID: 1667567
[TBL] [Abstract][Full Text] [Related]
9. [CEA determination in aspired fluid of cystic ovarian tumors and ovarian cysts and in ascites and serum samples of patients with ovarian tumors].
Kunze M; Büttner HH; Strache RR; Voss P; Briese V; Schrodt U
Zentralbl Gynakol; 1988; 110(16):1006-12. PubMed ID: 3188713
[TBL] [Abstract][Full Text] [Related]
10. Immunological comparison of ovarian and colonic CEA.
Burtin P; Lamerz R; Gendron MC; Maunoury MT; Schnabel G
Immunol Lett; 1982 Feb; 4(2):87-91. PubMed ID: 6174431
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulins reactive to carcinoembryonic antigen and their relationship to the antigen in malignant ascitic fluid of ovarian carcinoma.
Hill R; Khoo SK; Daunter B; Silburn PA; Mackay EV
Int J Cancer; 1982 Nov; 30(5):587-92. PubMed ID: 7152721
[TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen isotypes in tissue sections and loose cyst fluid cells of ovarian neoplasms.
Harłozińska A; Bar JK; Jothy S; Sedlaczek P; Slesak B; Richter R
Tumour Biol; 1993; 14(1):1-8. PubMed ID: 7684152
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen in human ovarian neoplasms.
Marchand A; Fenoglio CM; Pascal R; Richart RM; Bennett S
Cancer Res; 1975 Dec; 35(12):3807-10. PubMed ID: 1192434
[TBL] [Abstract][Full Text] [Related]
14. Improved specificity of the CA 125 enzyme immunoassay for ovarian carcinomas by use of the ratio of CA 125 to carcinoembryonic antigen.
Wu JT; Miya T; Knight JA; Knight DP
Clin Chem; 1988 Sep; 34(9):1853-7. PubMed ID: 2458203
[TBL] [Abstract][Full Text] [Related]
15. Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA.
Halila H; Huhtala ML; Haglund C; Nordling S; Stenman UH
Br J Cancer; 1987 Aug; 56(2):153-6. PubMed ID: 3117086
[TBL] [Abstract][Full Text] [Related]
16. [Immunochemical identification of carcinoembryonic antigen in ovarian adenocarcinoma and pseudomucinous cystoma extracts].
Tatarinov IuS; Kalashnikov VV; Borisenko SA; Griaznova IM; Vasil'eva NN
Biull Eksp Biol Med; 1975 Jan; 79(1):50-3. PubMed ID: 803383
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated antigen CA 195 in patients with mucinous ovarian tumours: a comparative analysis with CEA, TATI and CA 125 in serum specimens and cyst fluids.
de Bruijn HW; ten Hoor KA; Boonstra H; Marrink J; Krans M; Aalders JG
Tumour Biol; 1993; 14(2):105-15. PubMed ID: 8392219
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cellular phenotypes in tumor cyst and ascitic fluid from ovarian serous carcinoma.
Harlozinska A; Bar JK; Richter R; Cislo M
Acta Cytol; 1992; 36(6):869-74. PubMed ID: 1449024
[TBL] [Abstract][Full Text] [Related]
19. Isolation of tumour-associated immunoglobulins from ascitic fluid.
Hill R; Daunter B; Khoo SK; MacKay EV
Br J Cancer; 1978 Jul; 38(1):154-7. PubMed ID: 687514
[No Abstract] [Full Text] [Related]
20. Tumor and serum CEA content in gynecologic neoplasms.
Kula J; Richter R; Gawlikowski W; Harłozińska A
Neoplasma; 1984; 31(1):89-93. PubMed ID: 6322027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
